• BMS signs deal with Concerto HealthAI pharmatimes
    April 02, 2019
    Bristol-Myers Squibb and Concerto HealthAI have announced plans to apply artificial intelligence (AI) and real-world data to a diverse range of cancers in a multi-year strategic agreement.
PharmaSources Customer Service